Tirzepatide, a recently approved medication, is generating significant interest in the medical community as a viable treatment for both diabetes, type 2 and reducing body fat. This groundbreaking drug works by stimulating two different receptors, GLP-1 and GIP, leading to improved glucose control and significant fat loss in clinical trials . While